Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Benowitz

Showing results (271-280 of 291) with videos related to

Pageof 30
Sort By:
Pharmacology, Biochemistry, and Behavior|July 19, 2000
Nicotine blood levels and subjective craving for cigarettesM E Jarvik, D C Madsen, R E Olmstead, et al.
Tobacco Control|June 4, 2004
Reducing tobacco addiction through tobacco product regulationJ E Henningfield, N L Benowitz, G N Connolly, et al.
Clinical Pharmacology and Therapeutics|May 30, 2013
CYP2A6 genotype but not age determines cotinine half-life in infants and childrenD A Dempsey, N C Sambol, P Jacob, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 24, 2006
Evaluation of urinary trans-3'-hydroxycotinine as a biomarker of children's environmental tobacco smoke exposureG E Matt, P J E Quintana, S Liles, et al.
Tobacco Control|June 1, 2005
Toward a comprehensive long term nicotine policyN Gray, J E Henningfield, N L Benowitz, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 1993
Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteersJ C Forsyth, P D Mueller, C E Becker, et al.
The Journal of Clinical Investigation|January 1, 1994
Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokersM K Hellerstein, N L Benowitz, R A Neese, et al.
Journal of Neurophysiology|September 1, 1994
Role of vagal afferents and spinal pathways modulating inhibition of bradykinin-induced plasma extravasation by intrathecal nicotineF J Miao, W Jänig, M F Dallman, et al.
Clinical Pharmacology and Therapeutics|May 25, 2007
Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolismJ C Mwenifumbo, C N Lessov-Schlaggar, Q Zhou, et al.
Clinical Pharmacology and Therapeutics|March 13, 2009
Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokersM K Ho, J C Mwenifumbo, N Al Koudsi, et al.
Pageof 30

Showing results (271-280 of 291) with videos related to

Sort By:
Pageof 30
Pharmacology, Biochemistry, and Behavior|July 19, 2000
Nicotine blood levels and subjective craving for cigarettesM E Jarvik, D C Madsen, R E Olmstead, et al.
Tobacco Control|June 4, 2004
Reducing tobacco addiction through tobacco product regulationJ E Henningfield, N L Benowitz, G N Connolly, et al.
Clinical Pharmacology and Therapeutics|May 30, 2013
CYP2A6 genotype but not age determines cotinine half-life in infants and childrenD A Dempsey, N C Sambol, P Jacob, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 24, 2006
Evaluation of urinary trans-3'-hydroxycotinine as a biomarker of children's environmental tobacco smoke exposureG E Matt, P J E Quintana, S Liles, et al.
Tobacco Control|June 1, 2005
Toward a comprehensive long term nicotine policyN Gray, J E Henningfield, N L Benowitz, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 1993
Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteersJ C Forsyth, P D Mueller, C E Becker, et al.
The Journal of Clinical Investigation|January 1, 1994
Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokersM K Hellerstein, N L Benowitz, R A Neese, et al.
Journal of Neurophysiology|September 1, 1994
Role of vagal afferents and spinal pathways modulating inhibition of bradykinin-induced plasma extravasation by intrathecal nicotineF J Miao, W Jänig, M F Dallman, et al.
Clinical Pharmacology and Therapeutics|May 25, 2007
Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolismJ C Mwenifumbo, C N Lessov-Schlaggar, Q Zhou, et al.
Clinical Pharmacology and Therapeutics|March 13, 2009
Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokersM K Ho, J C Mwenifumbo, N Al Koudsi, et al.
Pageof 30